BioCentury | Aug 15, 2016

Serving returns

...treat cardiovascular diseases and SB-061 mimics aggrecan to treat osteoarthritis Ph I Tunitas Therapeutics Inc. Epsi-gam...
BioCentury | Oct 1, 2015
Financial News

Tunitas raises $10M in series A

...Tunitas develops fusion proteins that target receptors activated by allergens. It is developing lead candidate epsi-gam...
Items per page:
1 - 2 of 2